Quantum BioPharma's (QNTM.CN, QNTM) board of directors approved the settlement of C$123,487.43 owing to arm's length creditors and insiders of the company by issuing its Class B subordinate voting shares, it said late Monday.
The shares will be issued at a deemed price per share based on the lower of C$4.26 and the closing price of the Class B shares on the Canadian Securities Exchange on the trading day immediately before the date of the closing of the debt settlement, added Quantum BioPharma.
Shares of the company were last seen down C$0.05 to C$4.21 on the Canadian Securities Exchange.
Price: $4.21, Change: $-0.05, Percent Change: -1.17%